sustainability

The California Stem Cell Program's Paucity of Critics

Despite its billions, CIRM is little known to the public and even potential opponents

Nov 2 •

Six Month Pause on Research Applications at California's Stem Cell and Gene Therapy Program

Multibillion-dollar enterprise needs time to work through its sweeping, new priorities

Oct 4 •

Want to Help Plan the Financial Future of a Multibillion-Dollar, Biomedical, California Research Enterprise?

The job involves 'CIRM's lifespan' along with audits and accounting.

Aug 15 •

Text from UCLA Researcher Donald Kohn on his Bubble Baby Clinical Trial

Status report and treatment of five-year-old Jakob included

Jul 27 •

Dr. Moustache and the Bubble Baby Disease: A CIRM Success Story

More than 50 patients treated successfully, but a commercialization caveat

Jul 27 •

Trail Guide to $3.9 Billion in Looming Changes at California's Stem Cell and Gene Therapy Program

Who wins, who loses? The priority review is laying the groundwork for decisions about dollars.

Jul 25 •

Looking for Work? Want to Help Give Away Billions of Dollars?

The California stem cell agency is looking for six good helpers

Jul 12 •

Less Than Probing: Financial Examination of $12 Billion Stem Cell Research Program Skims Quickly Over the Numbers

Not discussed are CIRM's sustainability and its self-identified risks; session held behind closed electronic doors

Jun 5 •

Dysfunction, Bifurcated Management and $12 Billion: A Call for Reevalution of CIRM

Longtime member of CIRM financial oversight panel resigns, citing 'surpassed tolerance limits'

May 28 •

From CEO to Financial: Risks in California's Multibillion-Dollar Stem Cell/Genetic Research Program

CIRM identifies uncertainties involved in its efforts

May 27 •

CIRM's Priorities and Spending: From the Impact of Past Research Investments to Prevalance of Diseases in California

State funding for gene and stem cell therapies to involve "patient reach" and likelihood of regulatory approval

Apr 24 •

CIRM's 'Adventure with a Deadline:' How Billions will be Spent Pursuing Stem Cell and Gene Therapies

California refocusing spending priorities, dollars likely to go in different directions

Mar 26 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts